Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
- National Cancer Institute, United States
Additional files
-
All additional files
Any figure supplements, source code, source data, videos or supplementary files associated with this article are contained within this zip.
- https://cdn.elifesciences.org/articles/10279/elife-10279-supp-v1.zip
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
eLife 4:e10279.
https://doi.org/10.7554/eLife.10279
